Riskpilot← Back to searchSign inGet full accessValida Health ApS
APSActiveCVR 41344806Strandvejen 130BWholesale of pharmaceutical and medical goods · NACE 4646Est. 202010 employeeswww.validahealth.dk
Revenue 2024
DKK -148K
-77% vs 2023
EBITDA margin
1818.5%
-25% vs 2023
Equity ratio
0.9%
Financial strength
Net profit 2024
DKK -3,9M
-34% vs 2023
| Revenue | DKK -148K | -77% |
| EBITDA | DKK -2,7M | -25% |
| Net profit | DKK -3,9M | -34% |
| Total assets | DKK 1,6M | -49% |
| Equity | DKK 14K | -96% |
| Employees | 10 | — |
Legal name
Valida Health ApS
CVR number
41344806
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
7. maj 2020
Share capital
DKK 125.208
Employees
10 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en direktør i forening med et bestyrelsesmedlem eller af den samlede bestyrelse.
Company purpose
Virksomhedens formål er at udøve virksomhed med helbredstests og vaccination samt hermed beslægtet virksomhed.
Address
Strandvejen 130B
Phone
+4531402244
Email
info@validahealth.dk
Website
www.validahealth.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3.945 | 17.576 | 2.674 | -645 | -148 |
| Staff expenses | -1.125 | -5.011 | -3.226 | -1.511 | -2.551 |
| EBITDA | 2.820 | 12.565 | -553 | -2.156 | -2.700 |
| Depreciation & amort. | -0 | -169 | -420 | -1.479 | -364 |
| EBIT | 2.820 | 12.395 | -972 | -3.635 | -3.064 |
| Net financials | 1 | -316 | -242 | -64 | -393 |
| Profit before tax | 2.822 | 12.079 | -1.214 | -3.700 | -3.457 |
| Tax | 621 | 2.719 | -394 | -808 | 431 |
| Net profit | 2.201 | 9.360 | -820 | -2.892 | -3.888 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6.547 | 19.427 | 5.050 | 3.054 | 1.571 |
| Equity | 2.241 | 9.601 | 2.281 | 389 | 14 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 4.306 | 9.547 | 2.393 | 2.665 | 1.557 |
| Total debt | 4.306 | 9.547 | 2.393 | 2.665 | 1.557 |
EBITDA margin
-269990800.0%
This company
15.8%
Market median
-1708802632% vs market
20202024
Equity ratio
0.9%
This company
38.2%
Market median
-98% vs market
20202024
Return on equity
-27809.1%
This company
18.4%
Market median
-151236% vs market
20202024
Net profit margin
-388770800.0%
This company
8.1%
Market median
-4799639606% vs market
20202024
Asset turnover
-0.09×
This company
1.12×
Market median
-108% vs market
20202024
Debt / equity
111.40×
This company
0.62×
Market median
-17868% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-05-07 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LH Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
TS Management | Management | 2021 | — | — |
CL Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2025 | — | — | |
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
SCIENT. INVEST ApS | Company | 100.0% | 100.0% | 2025 |
Esox Consulting & Invest ApS | Company | 5.0% | 5.0% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SCIENT. INVEST ApS
Valida Health ApS Board members of Valida Health ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lykke Højriis Larsen | Chief Executive Officer | 0 companies |
| Titus Sixten Hinsch Gylvin | Management | 0 companies |
| Camilla Louise McGregor | Chief Executive Officer | 0 companies |
| Ulf Bech Christensen | Chairman | 0 companies |
| Rune Skovmand Bosselmann | Chairman | 0 companies |